- GlobeNewswire•11 hours ago
IRVINE, Calif., Feb. 23, 2017-- The following is issued on behalf of ChromaDex:. In January 2016, I issued a shareholder letter wherein I described in some detail my enthusiasm surrounding the enormous ...
- GlobeNewswire•yesterdayStudy Published in PAIN Reveals Nicotinamide Riboside is an Effective Tool in Relieving Chemotherapy-Induced Peripheral Neuropathy Induced by a Common Anticancer Agent
IRVINE, Calif., Feb. 22, 2017-- ChromaDex Corporation an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, ...
- GlobeNewswire•2 days ago
IRVINE, Calif., Feb. 21, 2017-- ChromaDex Corp., an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, ...
CDXC : Summary for CHROMADEX CORP - Yahoo Finance
ChromaDex Corporation (CDXC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.50 x 1000|
|Ask||4.24 x 200|
|Day's Range||2.77 - 2.94|
|52 Week Range||2.25 - 3.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-47.83|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|